TBPH icon

Theravance Biopharma

105 hedge funds and large institutions have $1.32B invested in Theravance Biopharma in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 18 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

less first-time investments, than exits

New positions opened: | Existing positions closed:

3% less funds holding

Funds holding: 108105 (-3)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

47% less call options, than puts

Call options by funds: $1.52M | Put options by funds: $2.86M

Holders
105
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.52M
Puts
$2.86M
Net Calls
Net Calls Change

Top Sellers

1 -$9.54M
2 -$6.07M
3 -$4.49M
4
Millennium Management
Millennium Management
New York
-$2.6M
5
Morgan Stanley
Morgan Stanley
New York
-$1.32M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$5.29M
27
$4.89M
28
$4.88M
29
$4.62M
30
$3.93M
31
$3.25M
32
$2.35M
33
$2.31M
34
$2.16M
35
$2.07M
36
$1.91M
37
$1.9M
38
$1.75M
39
$1.72M
40
$1.49M
41
$1.44M
42
$1.32M
43
$1.32M
44
$1M
45
$1M
46
$975K
47
$939K
48
$924K
49
$881K
50
$872K